Atossa Therapeutics, Inc. Common Stock ATOS
$4.70
-3.09%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-37,641,000
- Net Margin
- —
- Return on Equity
- -123.47%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.37
- Price / Sales
- —
Over the trailing twelve months, Atossa Therapeutics, Inc. Common Stock generated revenue of — and net income of $-37,641,000.
Key Stats
- Last Close
- $4.70
- Market Cap
- $41.77 million
- 52-Week Range
- $3.76 – $19.35
- Average Volume
- 49K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.